These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17249650)

  • 1. Synthesis and cell-based activity of a potent and selective protein tyrosine phosphatase 1B inhibitor prodrug.
    Boutselis IG; Yu X; Zhang ZY; Borch RF
    J Med Chem; 2007 Feb; 50(4):856-64. PubMed ID: 17249650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics.
    Combs AP; Yue EW; Bower M; Ala PJ; Wayland B; Douty B; Takvorian A; Polam P; Wasserman Z; Zhu W; Crawley ML; Pruitt J; Sparks R; Glass B; Modi D; McLaughlin E; Bostrom L; Li M; Galya L; Blom K; Hillman M; Gonneville L; Reid BG; Wei M; Becker-Pasha M; Klabe R; Huber R; Li Y; Hollis G; Burn TC; Wynn R; Liu P; Metcalf B
    J Med Chem; 2005 Oct; 48(21):6544-8. PubMed ID: 16220970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic.
    Combs AP; Zhu W; Crawley ML; Glass B; Polam P; Sparks RB; Modi D; Takvorian A; McLaughlin E; Yue EW; Wasserman Z; Bower M; Wei M; Rupar M; Ala PJ; Reid BM; Ellis D; Gonneville L; Emm T; Taylor N; Yeleswaram S; Li Y; Wynn R; Burn TC; Hollis G; Liu PC; Metcalf B
    J Med Chem; 2006 Jun; 49(13):3774-89. PubMed ID: 16789735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrug delivery of novel PTP1B inhibitors to enhance insulin signalling.
    Erbe DV; Klaman LD; Wilson DP; Wan ZK; Kirincich SJ; Will S; Xu X; Kung L; Wang S; Tam S; Lee J; Tobin JF
    Diabetes Obes Metab; 2009 Jun; 11(6):579-88. PubMed ID: 19383031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands.
    Liu G; Xin Z; Liang H; Abad-Zapatero C; Hajduk PJ; Janowick DA; Szczepankiewicz BG; Pei Z; Hutchins CW; Ballaron SJ; Stashko MA; Lubben TH; Berg CE; Rondinone CM; Trevillyan JM; Jirousek MR
    J Med Chem; 2003 Jul; 46(16):3437-40. PubMed ID: 12877578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate.
    Lee H; Xie L; Luo Y; Lee SY; Lawrence DS; Wang XB; Sotgia F; Lisanti MP; Zhang ZY
    Biochemistry; 2006 Jan; 45(1):234-40. PubMed ID: 16388599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and structure-activity relationships of novel sulfonamides as potent PTP1B inhibitors.
    Holmes CP; Li X; Pan Y; Xu C; Bhandari A; Moody CM; Miguel JA; Ferla SW; De Francisco MN; Frederick BT; Zhou S; Macher N; Jang L; Irvine JD; Grove JR
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4336-41. PubMed ID: 16046123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.
    Lorenzo M; Fernández-Veledo S; Vila-Bedmar R; Garcia-Guerra L; De Alvaro C; Nieto-Vazquez I
    J Anim Sci; 2008 Apr; 86(14 Suppl):E94-104. PubMed ID: 17940160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site.
    Wilson DP; Wan ZK; Xu WX; Kirincich SJ; Follows BC; Joseph-McCarthy D; Foreman K; Moretto A; Wu J; Zhu M; Binnun E; Zhang YL; Tam M; Erbe DV; Tobin J; Xu X; Leung L; Shilling A; Tam SY; Mansour TS; Lee J
    J Med Chem; 2007 Sep; 50(19):4681-98. PubMed ID: 17705360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
    Stuible M; Zhao L; Aubry I; Schmidt-Arras D; Böhmer FD; Li CJ; Tremblay ML
    Chembiochem; 2007 Jan; 8(2):179-86. PubMed ID: 17191286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of functionalized acetophenones as protein tyrosine phosphatase 1B inhibitors.
    Dixit M; Tripathi BK; Srivastava AK; Goel A
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3394-7. PubMed ID: 15951172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1B.
    Liu G; Szczepankiewicz BG; Pei Z; Janowick DA; Xin Z; Hajduk PJ; Abad-Zapatero C; Liang H; Hutchins CW; Fesik SW; Ballaron SJ; Stashko MA; Lubben T; Mika AK; Zinker BA; Trevillyan JM; Jirousek MR
    J Med Chem; 2003 May; 46(11):2093-103. PubMed ID: 12747781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTP1B inhibitors: synthesis and evaluation of difluoro-methylenephosphonate bioisosteres on a sulfonamide scaffold.
    Holmes CP; Li X; Pan Y; Xu C; Bhandari A; Moody CM; Miguel JA; Ferla SW; De Francisco MN; Frederick BT; Zhou S; Macher N; Jang L; Irvine JD; Grove JR
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2719-24. PubMed ID: 18372175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor.
    Liu G; Xin Z; Pei Z; Hajduk PJ; Abad-Zapatero C; Hutchins CW; Zhao H; Lubben TH; Ballaron SJ; Haasch DL; Kaszubska W; Rondinone CM; Trevillyan JM; Jirousek MR
    J Med Chem; 2003 Sep; 46(20):4232-5. PubMed ID: 13678400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
    Koren S; Fantus IG
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors.
    Sparks RB; Polam P; Zhu W; Crawley ML; Takvorian A; McLaughlin E; Wei M; Ala PJ; Gonneville L; Taylor N; Li Y; Wynn R; Burn TC; Liu PC; Combs AP
    Bioorg Med Chem Lett; 2007 Feb; 17(3):736-40. PubMed ID: 17097290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors.
    Zhao H; Liu G; Xin Z; Serby MD; Pei Z; Szczepankiewicz BG; Hajduk PJ; Abad-Zapatero C; Hutchins CW; Lubben TH; Ballaron SJ; Haasch DL; Kaszubska W; Rondinone CM; Trevillyan JM; Jirousek MR
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5543-6. PubMed ID: 15482920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of protein tyrosine phosphatase 1B by lignans from Myristica fragrans.
    Yang S; Na MK; Jang JP; Kim KA; Kim BY; Sung NJ; Oh WK; Ahn JS
    Phytother Res; 2006 Aug; 20(8):680-2. PubMed ID: 16752372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
    Zhang S; Zhang ZY
    Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: synthesis and structure-activity relationships of a peptide scaffold.
    Yue EW; Wayland B; Douty B; Crawley ML; McLaughlin E; Takvorian A; Wasserman Z; Bower MJ; Wei M; Li Y; Ala PJ; Gonneville L; Wynn R; Burn TC; Liu PC; Combs AP
    Bioorg Med Chem; 2006 Sep; 14(17):5833-49. PubMed ID: 16769216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.